Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Sibel Health

Explore full profile

Develops a neonatal epidermal system designed for wireless vital signs monitoring

Evanston, United StatesFounded 2018Health Tech & Medtech
Valuation $100–500M Latest valuation · 2025
Revenue $1–10M Latest reported FY
Headcount 100–500 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Sibel Health and the history behind them.

About Sibel Health

Sibel Health is a pioneering company in the healthcare technology sector, focusing on improving patient outcomes through innovative medical monitoring solutions. The company operates in the global healthcare market, serving a diverse range of clients from neonatal to adult care. Sibel Health's primary product is the ADAM sensor, a sophisticated device designed to capture detailed and accurate physiological data. This sensor is equipped with advanced features such as a three-axis accelerometer, gyroscope, temperature sensing, and a BLE (Bluetooth Low Energy) radio, all encapsulated in a waterproof, medical-grade silicone casing. The ADAM sensor is designed for single-use with an adhesive that gently attaches to the skin, making it suitable for continuous monitoring.

Read full description

The company's business model revolves around providing these advanced monitoring solutions to healthcare providers, clinical researchers, and hospitals. By offering FDA-cleared devices, Sibel Health ensures that its products meet stringent regulatory standards, which is crucial for gaining trust and widespread adoption in the medical community. The company generates revenue through the sale of its sensors and related monitoring systems, as well as through data-driven insights that help healthcare providers make better clinical decisions.

Sibel Health's mission is to deliver better health data for all, enabling proactive monitoring and intervention. This mission is driven by the belief that the most critical decisions in medicine are based on accurate and reliable data. By providing high-quality health data, Sibel Health aims to improve patient outcomes, whether in clinical trials or everyday medical care.

In summary, Sibel Health is at the forefront of healthcare innovation, offering advanced monitoring solutions that provide critical health data to improve patient care and outcomes.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2018
Headquarters
Evanston, United States
Employees
103
Open positions
6
Dealroom signal
74.7/100
Industry
Health, Enterprise Software
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Health Diagnostics, Spinout, Wearable, Hard Tech, remote health monitoring, DT and LS, science-based
Technology
Deep Tech, Autonomous & Sensor Tech
Business model
SaaS
Client focus
b2b

Latest news

Press, funding announcements and product moves mentioning Sibel Health.

See all news

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing Oct 2025 $9M $150M Samsung Next · Maruho
SERIES COther financing Mar 2025 $30M $120M Dräger · Steele Foundation for Hope
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Sibel Health website traffic

Latest recorded traffic for Sibel Health is 5.4K monthly website visits, up 35% over the last three months. Sibel Health's team declined 1% over the past year.

Latest monthly visits5.4K 3-month web change+35% 1-year team growth-1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Bill & Melinda Gates Foundation

Series A1 investor entered at this stage

  • Steele Foundation for Hope

Series B and later3 investors entered at this stage

Other known investors1 additional known investor

  • Northwestern University
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇺🇸 United States85.7%
🇰🇷 South Korea8.6%
🇺🇾 Uruguay4.3%
🇮🇳 India1.4%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Sibel Health on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sibel Health’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.